Shanghai Universal Biotech Co.Ltd. (301166) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Shanghai Universal Biotech Co.Ltd. stock ¥23.30, price ¥24.36, that is 4.4% below the price, quality 50 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Shanghai Universal Biotech Co.Ltd.
301166 · SHESolid company, but the stock is already about fairly priced and price moving sideways: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
59‑month range ¥22.92 – ¥122.84 · fair‑value band ¥17.47 – ¥29.12 · the ¥24.36 price screens above the ¥23.30 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Shanghai Universal Biotech Co.Ltd. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as immunology reagents, molecular biology reagents, cell biology reagents and biochemical reagents.
Show moreShow less
It also provides technical services, technology promotion, technology information exchange, scientific and technology training, technology consulting, technology incubation and other services, as well as experimental services and software solutions. The company also sells products online.
It serves colleges and universities, research institutes, hospitals, and biomedical companies. The company was founded in 2004 and is based in Shanghai, China.
Stock analysis
Shanghai Universal Biotech Co.Ltd. (301166) currently trades at ¥24.36, while our estimate is ¥23.30, so the stock looks roughly fairly valued today (gap 4.6%).
Show more
Valuation
None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ¥17.47 (bear) to ¥29.12 (bull), the price of ¥24.36 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Shanghai Universal Biotech Co.Ltd. reported revenue of 1.1B CNY in FY2025 versus 1.1B CNY in FY2021, a compound −0.6%/yr. Reported net income was −22.9M CNY in FY2025.
Key figures
Market cap 2.1B CNY (≈ $315M) Small · P/S ratio 2.14 · EPS (TTM) ¥-0.25 · Dividend yield 2.5% · Net margin −1.9% · Return on equity −1.1% · Return on assets (EBIT) 1.6% (5-year average) · Operating margin −4.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 15 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −4%, 301166 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch 301166, get fair value alerts →
Compare Shanghai Universal Biotech Co.Ltd. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 854 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $920.69 | $1,275.02 | +38% | vs 301166 |
| Vertex Pharmaceuticals Incorporated VRTX | $515.02 | $566.52 | +10% | vs 301166 |
| Samsung Biologics Co 207940 | ₩1,355,000 | ₩1,490,500 | +10% | vs 301166 |
| argenx SE ARGX | $925.70 | $908.40 | −2% | vs 301166 |
| CSL Limited CSL | A$197.29 | A$188.80 | −4% | vs 301166 |
| BeOne Medicines AG 6160 | HK$230.80 | HK$152.92 | −34% | vs 301166 |
| Moderna, Inc MRNA | $195.00 | $119.97 | −38% | vs 301166 |
| Revolution Medicines, Inc RVMD | $161.20 | $83.14 | −48% | vs 301166 |
| Celltrion, Inc 068270 | ₩213,000 | ₩74,574 | −65% | vs 301166 |
| Royalty Pharma plc RPRX | $68.45 | $19.01 | −72% | vs 301166 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Shanghai Universal Biotech Co.Ltd. (301166) overvalued or undervalued?
What is the fair value of 301166?
What is the quality score of 301166?
What is the price target for Shanghai Universal Biotech Co.Ltd. (301166)?
What is the Shanghai Universal Biotech Co.Ltd. stock forecast for 2026?
What is the revenue of Shanghai Universal Biotech Co.Ltd. (301166)?
Does Shanghai Universal Biotech Co.Ltd. pay a dividend?
How much is the dividend of Shanghai Universal Biotech Co.Ltd. (301166) and when is the ex-dividend date?
What is the intrinsic value of Shanghai Universal Biotech Co.Ltd. (301166)?
Is Shanghai Universal Biotech Co.Ltd. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 301166?
How much is Shanghai Universal Biotech Co.Ltd. worth?
What do the bullish and bearish scenarios say about 301166?
How solid is the balance sheet of Shanghai Universal Biotech Co.Ltd. (301166)?
How far is 301166 from its 52-week high?
Which stocks are comparable to Shanghai Universal Biotech Co.Ltd.?
Is Shanghai Universal Biotech Co.Ltd. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Shanghai Universal Biotech Co.Ltd. (301166)?
What should I pay attention to with Shanghai Universal Biotech Co.Ltd. right now?
Key figures of Shanghai Universal Biotech Co.Ltd.
How large is the market capitalisation of Shanghai Universal Biotech Co.Ltd. (301166)?
What is the P/S ratio of Shanghai Universal Biotech Co.Ltd. (301166)?
What are the earnings per share of Shanghai Universal Biotech Co.Ltd. (301166)?
What is the dividend yield of Shanghai Universal Biotech Co.Ltd. (301166)?
What is the net margin of Shanghai Universal Biotech Co.Ltd. (301166)?
What is the return on equity of Shanghai Universal Biotech Co.Ltd. (301166)?
What is the EBIT return on assets of Shanghai Universal Biotech Co.Ltd. (301166)?
What is the operating margin of Shanghai Universal Biotech Co.Ltd. (301166)?
How fast is revenue growing at Shanghai Universal Biotech Co.Ltd. (301166)?
How fast are earnings growing at Shanghai Universal Biotech Co.Ltd. (301166)?
How much free cash flow does Shanghai Universal Biotech Co.Ltd. (301166) generate?
Watch Shanghai Universal Biotech Co.Ltd. in the live analysis
One click puts Shanghai Universal Biotech Co.Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.